The ANDA Patent Certification Requirement and Thirty-Month Stay Provision: Is it Necessary?

DSpace/Manakin Repository

The ANDA Patent Certification Requirement and Thirty-Month Stay Provision: Is it Necessary?

Citable link to this page

. . . . . .

Title: The ANDA Patent Certification Requirement and Thirty-Month Stay Provision: Is it Necessary?
Author: Range, Brian
Citation: The ANDA Patent Certification Requirement and Thirty-Month Stay Provision: Is it Necessary? (2001 Third Year Paper)
Full Text & Related Files:
Abstract: Patent law and the Federal drug approval laws are both rather arcane and complex. The intersection of these two areas in the Hatch-Waxman Act is particularly complicated, and this perhaps explains the failure of the Act to consistently comply with core philosophical principles for supporting the modern intellectual property regime. The following paper addresses the problems arising from the thirty-month stay provision of the Hatch-Waxman Act, evaluates the legitimacy of the provision under accepted philosophical justifications for intellectual property, and suggests possible alternatives for addressing the failures of this provision.
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852164

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters